Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Rationale: Primary graft dysfunction (PGD) is the main cause of early morbidity and mortality after lung transplantation. Previous studies have yielded conflicting results for PGD risk factors. Objectives: We sought to identify donor, recipient, and perioperative risk factors for PGD. Methods: We performed a 10-center prospective cohort study enrolled between March 2002 and December 2010 (the Lung Transplant Outcomes Group). The primary outcome was International Society for Heart and Lung Transplantation grade 3 PGD at 48 or 72 hours post-transplant. The association of potential risk factors with PGD was analyzed using multivariable conditional logistic regression. Measurements and Main Results: A total of 1,255 patients from 10 centers were enrolled; 211 subjects (16.8%) developed grade 3 PGD. In multivariable models, independent risk factors for PGD were any history of donor smoking (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.2–2.6; P = 0.002); FiO2 during allograft reperfusion (OR, 1.1 per 10% increase in FiO2; 95% CI, 1.0–1.2; P = 0.01); single lung transplant (OR, 2; 95% CI, 1.2–3.3; P = 0.008); use of cardiopulmonary bypass (OR, 3.4; 95% CI, 2.2–5.3; P < 0.001); overweight (OR, 1.8; 95% CI, 1.2–2.7; P = 0.01) and obese (OR, 2.3; 95% CI, 1.3–3.9; P = 0.004) recipient body mass index; preoperative sarcoidosis (OR, 2.5; 95% CI, 1.1–5.6; P = 0.03) or pulmonary arterial hypertension (OR, 3.5; 95% CI, 1.6–7.7; P = 0.002); and mean pulmonary artery pressure (OR, 1.3 per 10 mm Hg increase; 95% CI, 1.1–1.5; P < 0.001). PGD was significantly associated with 90-day (relative risk, 4.8; absolute risk increase, 18%; P < 0.001) and 1-year (relative risk, 3; absolute risk increase, 23%; P < 0.001) mortality. Conclusions: We identified grade 3 PGD risk factors, several of which are potentially modifiable and should be prioritized for future research aimed at preventative strategies. Clinical trial registered with www.clinicaltrials.gov (NCT00552357).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We know from prior work that recipient characteristics including primary PH or pulmonary fibrosis and increasing mPAP are risk factors for PGD.29–31”
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Christie, J. D., Carby, M., Bag, R., Corris, P., Hertz, M., & Weill, D. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.11.049 · Cited by 762 · cited 1×
“In 2005, the International Society for Heart and Lung Transplantation (ISHLT) standardized the PGDdefinition to facilitate research on risk factors associated with the development of this syndrome (7).”
BackgroundSelf-citationChristie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Dipchand, A. I., Dobbels, F., Kirk, R., Rahmel, A. O., Stehlik, J., & Hertz, M. I. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.08.004 · Cited by 630 · cited 2×
“Additionally, the most recent ISHLT report includes 2004–2010 as a single era when presenting survival analyses (34).”
BackgroundSelf-citationTransfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study
Gajic, O., Rana, R., Winters, J. L., Yilmaz, M., Mendez, J. L., Rickman, O. B., O'Byrne, M. M., Evenson, L. K., Malinchoc, M., DeGoey, S. R., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-271oc · Cited by 430 · cited 1×
“Nonetheless, because blood product transfusion in-and-of-itself is associated with ALI in at-risk groups this finding may warrant further research into mechanisms of increased grade 3 PGD risk (31).”
Impact of Immediate Primary Lung Allograft Dysfunction on Bronchiolitis Obliterans Syndrome
Daud, S. A., Yusen, R. D., Meyers, B. F., Chakinala, M. M., Walter, M. J., Aloush, A. A., Patterson, G. A., Trulock, E. P., & Hachem, R. R. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1079oc · Cited by 420 · cited 5×
“Pulmonary arterial hypertension 12 (6) 28 (3)”
BackgroundMethodInfluentialPutensen, C., Theuerkauf, N., Zinserling, J., Wrigge, H., & Pelosi, P. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-8-200910200-00011 · Cited by 372
The Effect of Primary Graft Dysfunction on Survival after Lung Transplantation
Christie, J. D., Kotloff, R. M., Ahya, V. N., Tino, G., Pochettino, A., Gaughan, C., DeMissie, E., & Kimmel, S. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1243oc · Cited by 351 · cited 1×
“The incidence of PGD is 10–30% and is the major cause of mortality within the first post-transplant year (1, 2).”
BackgroundSelf-citationEISNER, M. D., THOMPSON, T., HUDSON, L. D., LUCE, J. M., HAYDEN, D., SCHOENFELD, D., MATTHAY, M. A., & the Acute Respiratory Distress Syndrome Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2011093 · Cited by 290
Clinical Risk Factors for Primary Graft Failure Following Lung Transplantation
Christie, J. D., Kotloff, R. M., Pochettino, A., Arcasoy, S. M., Rosengard, B. R., Landis, J. R., & Kimmel, S. E. (2003) · Chest · doi:10.1378/chest.124.4.1232 · Cited by 275 · cited 1×
“None of the previously identified donor variables, including sex, race, age, or mode of death were significantly associated with grade 3 PGD (14, 18, 20).”
BackgroundSelf-citationPrimary Graft Dysfunction and Long-term Pulmonary Function After Lung Transplantation
Whitson, B. A., Prekker, M. E., Herrington, C. S., Whelan, T. P. M., Radosevich, D. M., Hertz, M. I., & Dahlberg, P. S. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.07.018 · Cited by 265 · cited 1×
“PGD leads to increased duration of mechanical ventilation and intensive care unit length of stay, poor functional outcomes, and increased risk of bronchiolitis obliterans syndrome (3, 4).”
Background
Cited by
Items 201–300 of 698
Halpern, S. E., Wright, M. C., Madsen, G., Chow, B., Harris, C. S., Haney, J. C., Klapper, J. A., Bottiger, B. A., & Hartwig, M. G. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.07.015 · Cited by 22
Targeting mitochondrial complex I of CD177+ neutrophils alleviates lung ischemia-reperfusion injury
Wu, J., Gao, P., Yang, C., Zhuang, F., Luo, Y., Wen, F., Zhang, P., Wang, L., Xie, H., Dai, C., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102140 · Cited by 35
Extracorporeal Membrane Oxygenation: The New Jack-of-All-Trades?
Kwak, J., Majewski, M. B., & Jellish, W. S. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.09.031 · Cited by 22
Diamond, J. M., Cantu, E., Porteous, M. K., Suzuki, Y., Meyer, K. C., Lederer, D. J., Milewski, R. K., Arcasoy, S. M., D’Ovidio, F., Bacchetta, M. D., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14209 · Cited by 22
“dent readers, with adjudication, similar to previous studies (7,12,14).”
Self-citationScaravilli, V., Morlacchi, L. C., Merrino, A., Piacentino, E., Marasco, D., Zanella, A., Nosotti, M., Rosso, L., Polli, F., Blasi, F., et al. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.10.016 · Cited by 25
Li, D., Weinkauf, J. G., Hirji, A. S., Nagendran, J., Kapasi, A., Lien, D. C., & Halloran, K. M. (2020) · Transplantation · doi:10.1097/tp.0000000000003238 · Cited by 22
“Finally, in addition to pulmonary diagnosis, the other factor which affects both aTLC and PGD risk is recipient body mass index (BMI).(9,10) A sizing methodology utilizing aTLC would be desirable then, as it could feasibly function to integrate the effects of 2 common factors—pulmonary diagnosis and BMI—which may affe…”
BackgroundMethodObesity and Organ Transplantation: Successes, Failures, and Opportunities
DiCecco, S. R., & Francisco‐Ziller, N. (2014) · Nutrition in Clinical Practice · doi:10.1177/0884533613518585 · Cited by 25
“When looking at the effect of obesity on immediate postlung transplantation, 7 studies showed that obesity did increase 90-day mortality and the incidence of grade 3 primary graft dysfunction, which is an acute form of lung injury within 48– 72 hours and is the leading cause of morbidity and mortality through 1 year p…”
BackgroundZeriouh, M., Sabashnikov, A., Mohite, P. N., Zych, B., Patil, N. P., García‐Sáez, D., Koch, A., Weymann, A., Soresi, S., Wippermann, J., et al. (2016) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivw135 · Cited by 22
“However, the overall incidence of Grade 3 PGD, the leading cause of early morbidity and mortality after LTx [19, 20], did not sig-”
Acute postoperative management after lung transplantation
Potestio, C. P., Jordan, D. A., & Kachulis, B. (2017) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2017.07.004 · Cited by 22
Impact of anastomosis time during lung transplantation on primary graft dysfunction
Vandervelde, C. M., Vos, R., Vanluyten, C., Fieuws, S., Verleden, S. E., Slambrouck, J. V., Leyn, P. D., Coosemans, W., Nafteux, P. R., Decaluwé, H., et al. (2022) · American Journal of Transplantation · doi:10.1111/ajt.16957 · Cited by 21
Chacon‐Alberty, L., Kanchi, R. S., Ye, S., Hochman‐Mendez, C., Daoud, D., Coarfa, C., Li, M., Grimm, S. L., Baz, M. A., Rosas, I. O., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20085-y · Cited by 21
Jenkins, J., Verdiner, R. E., Omar, A., Farina, J., Wilson, R., D’Cunha, J., & dos Santos, P. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341675 · Cited by 25
Role of innate immunity in primary graft dysfunction after lung transplantation
Diamond, J. M., & Wigfield, C. H. (2013) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283651994 · Cited by 21
Self-citationHumoral Human Lung Allograft Rejection by Tissue-Restricted Non-HLA Antibodies
Fernandez, R., Chiu, S. F., Raparia, K., Garcha, P., Farver, C. F., Budev, M. M., Tambur, A. R., DeCamp, M. M., Budinger, S., Perlman, H., et al. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.03.042 · Cited by 21
“Despite that, Recipient 1 developed PGD but not Recipient 2.”
BackgroundInfluentialImpact of Obesity on Heart and Lung Transplantation: Does Pre-Transplant Obesity Affect Outcomes?
Bozso, S. J., Nagendran, J., Gill, R. S., Freed, D. H., & Nagendran, J. (2017) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.12.002 · Cited by 21
Anesthesia for Lung Transplantation
Nicoara, A., & Anderson-Dam, J. (2017) · Anesthesiology Clinics · doi:10.1016/j.anclin.2017.05.003 · Cited by 21
Taka, H., Miyoshi, K., Kurosaki, T., Douguchi, T., Itoh, H., Sugimoto, S., Yamane, M., Kobayashi, M., Kasahara, S., & Oto, T. (2019) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-019-01067-w · Cited by 21
Martin, A. K., Harrison, B. A., Fritz, A. V., Landolfo, K. P., Makey, I. A., Sareyyüpoğlu, B., Brown, T. E., Johnson, J. L., Pham, S. M., & Thomas, M. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.15029 · Cited by 21
Natalini, J. G., & Diamond, J. M. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1728794 · Cited by 22
Self-citationZeng, Z., Chen, W., Moshensky, A., Shakir, Z., Khan, R., Alexander, L. E. C., Ware, L. B., Aldaz, C. M., Jacobson, J. R., Dudek, S. M., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0145oc · Cited by 20
Self-citationNew models for donor-recipient matching in lung transplantations
Dueñas-Jurado, J. M., Gutiérrez, P. A., Casado-Adam, Á., Santos-Luna, F., Velázquez, Á. S., Cárcel, S., Robles-Arista, C. J. C., & Hervás‐Martínez, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252148 · Cited by 23
“96, although this has been considered an independent factor of primary graft dysfunction and, therefore, increases the probability of death [22, 23, 36].”
BackgroundResultInfluentialIntraoperative Red Blood Cell Transfusion and Primary Graft Dysfunction After Lung Transplantation
Subramaniam, K., Loor, G., Chan, E. G., Bottiger, B., Ius, F., Hartwig, M. G., Daoud, D., Zhang, Q., Wei, Q., Villavicencio-Theoduloz, M. A., et al. (2023) · Transplantation · doi:10.1097/tp.0000000000004545 · Cited by 24
Impact of donor lung pathogenic bacteria on patient outcomes in the immediate post‐transplant period
Ahmad, O., Shafii, A. E., Mannino, D. M., Choate, R., & Baz, M. A. (2018) · Transplant Infectious Disease · doi:10.1111/tid.12986 · Cited by 20
Li, D., Weinkauf, J. G., Hirji, A. S., Kapasi, A., Lien, D. C., Nagendran, J., Kim, D., Ezekowitz, J. A., & Halloran, K. M. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.02.010 · Cited by 20
Welte, T., Len, Ó., Muñóz, P., Romani, L. R., Lewis, R. E., & Perrella, A. (2019) · Infection · doi:10.1007/s15010-019-01360-z · Cited by 22
Shah, R. J., Wickersham, N. E., Lederer, D. J., Palmer, S. M., Cantu, E., Diamond, J. M., Kawut, S. M., Lama, V. N., Bhorade, S. M., Crespo, M., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12541 · Cited by 21
“collected prospectively for all subjects as described previously (5,7,10).”
InfluentialSelf-citationSnell, G. I., Westall, G. P., & Oto, T. (2013) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283637fdc · Cited by 20
Ex vivo treatment with inhaled N-acetylcysteine in porcine lung transplantation
Yamada, Y., İskender, İ., Arni, S., Hillinger, S., Coşgun, T., Yu, K., Jungraithmayr, W., Cesarovic, N., Weder, W., & İnci, İ. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.06.061 · Cited by 20
Long-term outcomes of patients with primary graft dysfunction after cardiac transplantation
Squiers, J. J., DiMaio, J. M., Zyl, J. S. V., Lima, B., Gonzalez-Stawisnksi, G., Rafael, A., Meyer, D. M., & HALL, S. A. (2021) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezab177 · Cited by 19
Criner, R. N., Clausen, E. S., & Cantu, E. (2021) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000876 · Cited by 21
“Risk factors initially identified for PGD, such as African American recipient race, donor and recipient female sex, and gender mismatch, have not been validated as lung transplant cohort data and subsequent analyses become more robust [5,6,17].”
BackgroundSelf-citationChacon‐Alberty, L., Ye, S., Elsenousi, A. E., Hills, E. E., King, M., D'Silva, E., León-Peña, A. A., Salan‐Gomez, M., Li, M., Hochman‐Mendez, C., et al. (2022) · Artificial Organs · doi:10.1111/aor.14474 · Cited by 20
Laskey, D. H., Housman, B., Dawodu, G., & Scheinin, S. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010192 · Cited by 20
“…a higher blood transfusion requirement, a higher need for post-operative ECMO support, a higher re-intubation rate, high rates of kidney injury and need for hemodialysis, longer ICU stays, higher incidences of PGD grade 3 [32], as well as overall in-hospital mortality when compared with ECMO use.”
BackgroundResultNew horizons of non-emergent use of extracorporeal membranous oxygenator support.
Makdisi, G., Makdisi, P. B., & Wang, I. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2016.02.04 · Cited by 19
“The use of CPB was cited as an independent factor associated with primary graft dysfunction (56).”
BackgroundShah, P. R., Boisen, M. L., Winger, D. G., Márquez, J. M. S., Bermudez, C. A., Bhama, J. K., Shigemura, N., D’Cunha, J., & Subramaniam, K. (2016) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.08.021 · Cited by 19
Self-citationRefining the Lung Allocation Score Models Fails to Improve Discrimination Performance
Dalton, J. E., Lehr, C. J., Gunsalus, P. R., Mourany, L., & Valapour, M. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.08.2217 · Cited by 23
Lung transplantation: overall approach regarding its major aspects
de Camargo, P. C. L. B., Teixeira, R. H. D. O. B., Carraro, R. M., Campos, S. V., Afonso, J. E., Costa, A. N., Fernandes, L. M., Abdalla, L. G., Samano, M. N., & Pêgo‐Fernandes, P. M. (2015) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562015000000100 · Cited by 19
“Major risk factors for primary graft dysfunction include the use of cardiopulmonary bypass during surgery, a previous diagnosis of idiopathic pulmonary fibrosis, a previous diagnosis of pulmonary arterial hypertension, significant donor smoking history, and a high BMI.(10,11)”
BackgroundLung transplantation for pulmonary hypertension
Hwalek, A. E., Rosenheck, J. P., & Whitson, B. A. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-2021-20 · Cited by 21
“Despite this, newer studies support the transition to ECLS as CPB has been identified as an independent risk factor for primary graft dysfunction (50-52).”
Daoud, D., Chacon‐Alberty, L., Wei, Q., Hochman‐Mendez, C., Virk, M. H. M., Mase, J., Jindra, P., Cusick, M. F., Choi, H., Debolske, N., et al. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-20-3564 · Cited by 21
“Of note, our ECLS practice has evolved from use of cardiopulmonary bypass, a known risk factor for PGD, to the use of ECMO, considered by some to reduce PGD (5,12).”
BackgroundMethodResultInfluentialLuu, H. Y., Santos, J., Isaza, E., Brzeziński, M., & Kukreja, J. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-22-1387 · Cited by 22
“5-fold increased risk of PGD) (13,16) and mortality (54) attributed to PGD.”
Wilkey, B., & Abrams, B. A. (2019) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253219881980 · Cited by 19
Charles, E. J., Chordia, M. D., Zhao, Y., Zhang, Y., Mehaffey, J. H., Glover, D. K., Dimastromatteo, J., Chancellor, W. Z., Sharma, A. K., Kron, I. L., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00220.2018 · Cited by 18
Primary graft dysfunction: what we know
Clausen, E. S., & Cantu, E. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-2021-18 · Cited by 19
“with both 90-day and 1-year mortality (1,2,5).”
Self-citationClinical Risk Factors for Primary Graft Dysfunction in a Low-volume Lung Transplantation Center
Nosotti, M., Palleschi, A., Rosso, L., Tosi, D., Mendogni, P., Righi, I., Montoli, M., Crotti, S., & Russo, R. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2014.07.042 · Cited by 18
Donation after Brain Death versus Donation after Circulatory Death: Lung Donor Management Issues
Levvey, B. J., Levin, K., Paraskeva, M. A., Westall, G. P., & Snell, G. I. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1615820 · Cited by 18
Incidence and variables associated with 30‐day mortality after lung transplantation
Banga, A., Mohanka, M. R., Mullins, J., Bollineni, S., Kaza, V., Huffman, L. C., Peltz, M., Bajona, P., Wait, M. A., & Torres, F. (2018) · Clinical Transplantation · doi:10.1111/ctr.13468 · Cited by 18
Lee, J. S., & Fischer, A. (2016) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2016.1139454 · Cited by 18
“) may adversely affect survival and graft function following transplantation [94,95].”
BackgroundSelf-citationRisk factors and outcome of primary graft dysfunction after lung transplantation in Korea
Moon, S. W., Park, M. S., Lee, J. G., Jung, J. Y., Kang, Y. A., Ki, Y. S., Kim, Y. S., Chang, J., Paik, H. C., & Kim, S. Y. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.11.48 · Cited by 17
“Thabut and colleagues found that cold ischemic time was associated with poor outcomes among patients with PGD (14), whilst other groups reported that there was no association between ischemic time and PGD (5,8,15,16).”
BackgroundResultInfluentialSelf-citationLung Transplantation in Pulmonary Hypertension: A Multidisciplinary Unit's Management Experience
Quezada-Loaiza, C. A., Gafas, A. D. P., Pérez, V., Alonso-Moralejo, R., Monteagudo, L. J., Real, M. I., López, E., Cortes, M., Meneses, J. C., Hernández‐González, I., et al. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2018.02.073 · Cited by 17
Lightle, W. R., Daoud, D., & Loor, G. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.03.32 · Cited by 17
“The results showed a 30% chance of developing PGD3 with standard ice preservation, which was consistent with prior observations (4,11).”
ResultVajter, J., Vachtenheim, J., Přikrylová, Z., Beroušek, J., Vymazal, T., Lischke, R., Martin, A. K., & Durila, M. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02372-0 · Cited by 18
Comparison of mechanical cardiopulmonary support strategies during lung transplantation
Weingarten, N., Schraufnagel, D. P., Plitt, G. D., Zaki, A. L., Ayyat, K. S., & Elgharably, H. (2020) · Expert Review of Medical Devices · doi:10.1080/17434440.2020.1841630 · Cited by 18
White, A., Wang, Z., Wang, X., King, M., Guo, C. R., Mantsounga, C., Ayala, A., Morrison, A., Choudhary, G., Sellke, F. W., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102467 · Cited by 17
Self-citationShiraishi, K., Morley, M. P., Jones, D. L., Zhao, G., Weiner, A. I., Basil, M. C., Cantu, E., Ferguson, L. T., Oyster, M., Babu, A., et al. (2024) · npj Regenerative Medicine · doi:10.1038/s41536-023-00344-w · Cited by 17
“All mouse experiments were performed in accordance with protocols approved under the guidance of the Institutional Animal Care and Use Committee of the University of Pennsylvania.”
InfluentialSelf-citationScoring donor lungs for graft failure risk: The Lung Donor Risk Index (LDRI)
Cantu, E., Diamond, J. M., Ganjoo, N., Nottigham, A., Ramon, C. V., McCurry, M., Friskey, J., Dun, J., Anderson, M. R., Lisowski, J., et al. (2024) · American Journal of Transplantation · doi:10.1016/j.ajt.2024.01.022 · Cited by 16
Self-citationJu, Y., Li, H., Zhuo, Z.-P., Yang, Q., & Gao, W. (2025) · Immunobiology · doi:10.1016/j.imbio.2024.152865 · Cited by 17
Narm, K. S., Lee, S., Suh, J. W., Kim, A., Lee, J. G., Park, M. S., Kim, S. Y., Song, J. H., Jeong, S. J., & Paik, H. C. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.07.046 · Cited by 16
Self-citationReview of donor and recipient surgical procedures in lung transplantation
Nguyen, D. C., Loor, G., Carrott, P. W., & Shafii, A. E. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.06.31 · Cited by 16
Cigarette Smoking and ARDS After Blunt Trauma
Moazed, F., Hendrickson, C. M., Conroy, A., Kornblith, L. Z., Benowitz, N. L., Delucchi, K., Cohen, M. J. M., & Calfee, C. S. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.05.603 · Cited by 16
Intraoperative Extracorporeal Circulatory Support in Lung Transplantation for Pulmonary Fibrosis
Salman, J., Bernhard, B.-A., Ius, F., Poyanmehr, R., Sommer, W., Aburahma, K., Alhadidi, H., Siemeni, T., Kuehn, C., Avsar, M., et al. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.06.083 · Cited by 16
Benazzo, A., Schwarz, S., Frommlet, F., Sinn, K., Schweiger, T., Klikovits, T., Hoda, A. M., Moser, B., Matilla, J. R., Vámos, F. R., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.10.008 · Cited by 16
Knight, J., Hill, A., Melnyk, V., Doney, L., D’Cunha, J., Kenkre, T., Subramaniam, K., & Howard-Quijano, K. (2021) · Transplantation · doi:10.1097/tp.0000000000003814 · Cited by 17
Pulmonary Hypertensive Crisis on Induction of Anesthesia
Schisler, T., Marquez, J. M., Hilmi, I. A., & Subramaniam, K. (2016) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253216652222 · Cited by 16
“PAH is also a risk factor for the development of primary graft dysfunction after lung transplantation.(7,8) In this report, we focus on critical events that occur during induction of anesthesia and provide some evidence-based guidelines and recommendations for safe practice based on the experiences at our high-volume…”
BackgroundClinical implications of donor age: A single-institution analysis spanning 3 decades
Holley, C. T., Kelly, R. F., Shumway, S. J., Brown, R. Z., Hertz, M. I., Rudser, K. D., Quinlan, C. W., Cich, I., & Loor, G. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.06.029 · Cited by 17
Pettenuzzo, T., Faggi, G., Gregorio, G. D., Schiavon, M., Marulli, G., Gregori, D., Rea, F., Ori, C., & Feltracco, P. (2018) · Progress in Transplantation · doi:10.1177/1526924818765816 · Cited by 16
Collagen type-V is a danger signal associated with primary graft dysfunction in lung transplantation
Zaffiri, L., Shah, R., Stearman, R. S., Rothhaar, K., Emtiazjoo, A. M., Yoshimoto, M., Fisher, A. J., Mickler, E. A., Gartenhaus, M. D., Cohort, L. T. O. G., et al. (2019) · Transplant Immunology · doi:10.1016/j.trim.2019.101224 · Cited by 16
Self-citationStone, J. P., Ball, A. L., Critchley, W. R., Yonan, N. A., Liao, Q., Sjöberg, T., Steen, S., & Fildes, J. E. (2020) · Transplantation · doi:10.1097/tp.0000000000003338 · Cited by 16
Diamond, J. M., Anderson, M. R., Cantu, E., Clausen, E. S., Shashaty, M. G. S., Kalman, L., Oyster, M. L., Crespo, M. M., Bermudez, C. A., Benvenuto, L. J., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2023.11.019 · Cited by 17
Self-citationMa, W., Oh, I. Y., Luo, Y., Kumar, S., Gupta, A., Lai, A. M., Puri, V., Kreisel, D., Gelman, A. E., Nava, R. G., et al. (2025) · American Journal of Transplantation · doi:10.1016/j.ajt.2025.01.039 · Cited by 17
Early Graft Dysfunction After Lung Transplantation
Rosenheck, J. P., Pietras, C., & Cantu, E. (2018) · Current Pulmonology Reports · doi:10.1007/s13665-018-0213-4 · Cited by 16
Self-citationCritical Care of Patients After Pulmonary Thromboendarterectomy
Kratzert, W. B., Boyd, E., Saggar, R., & Channick, R. N. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.03.005 · Cited by 15
Anesthetic considerations in lung transplantation: past, present and future
Murray, A. W., Boisen, M. L., Fritz, A. V., Renew, J. R., & Martin, A. K. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-2021-10 · Cited by 16
Elmaleh, Y. D., de Tymowski, C., Zappella, N., Jean‐Baptiste, S., Tran‐Dinh, A., Tanaka, S., Yung, S., Lortat‐Jacob, B., Mal, H., Castier, Y., et al. (2021) · Clinical Transplantation · doi:10.1111/ctr.14407 · Cited by 15
“Death at day 90 (n (%)) 7 (15) 13 (13) .”
InfluentialLung transplantation for acute exacerbation of interstitial lung disease
Chizinga, M., Machuca, T., Shahmohammadi, A., Patel, D. C., Innabi, A., Alzghoul, B. N., Scheuble, V., Pipkin, M., Mehrad, B., Peláez, A., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215681 · Cited by 16
Intraoperative support during lung transplantation
dos Santos, P. R., & D’Cunha, J. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-1166 · Cited by 15
“In this situation, it is vital to have a comprehensive approach to the donor and recipient, including the intraoperative period (6).”
BackgroundThe liver-first approach for combined lung and liver transplantation
Salman, J., Grannas, G., Ius, F., Sommer, W., Siemeni, T., Avsar, M., Kuehn, C., Boethig, D., Fleißner, F., Bobylev, D., et al. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy217 · Cited by 15
Critical Care after Lung Transplantation
Kim, S. Y., Jeong, S. J., Lee, J. G., Park, M. S., Paik, H. C., Na, S., & Kim, J. (2018) · Acute and Critical Care · doi:10.4266/acc.2018.00360 · Cited by 17
“The PGD score at 72 hours may be the most important time-point for predicting survival [2].”
BackgroundSelf-citationOda, H., Tanaka, S., Shinohara, M., Morimura, Y., Yokoyama, Y., Kayawake, H., Yamada, Y., Yutaka, Y., Ohsumi, A., Nakajima, D., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003987 · Cited by 15
Hernandez-Morgan, M., Neelankavil, J. P., Grogan, T., Hong, B., Wingert, T., & Methangkool, E. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.10.045 · Cited by 15
Mechanical Ventilation after Lung Transplantation. It’s Time for a Trial
Diamond, J. M., & Ahya, V. N. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201403-104ed · Cited by 15
Self-citationExtracorporeal life support during lung transplantation
Coster, J. N., & Loor, G. (2021) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-021-01175-4 · Cited by 14
“[1] of the Lung Transplant Outcomes Group determined that only 37% of lung transplantations were performed with CPB.”
BackgroundInfluentialWhen the Battle is Lost and Won: Delayed Chest Closure After Bilateral Lung Transplantation
Soresi, S., Sabashnikov, A., Weymann, A., Zeriouh, M., Simon, A. R., & Popov, A. (2015) · Medical science monitor basic research/Medical science monitor. Basic research · doi:10.12659/msmbr.895419 · Cited by 14
“After maximizing the medical therapy, the next step is inevitably a transition to an ECMO, with potentially serious complications [2].”
BackgroundSubramaniam, K., Rio, J. M. D., Wilkey, B., Kumar, A., Tawil, J. N., Subramani, S., Tani, M., Sánchez, P. G., & Mandell, M. S. (2020) · Clinical Transplantation · doi:10.1111/ctr.13996 · Cited by 14
Al‐Naamani, N., Pan, H., Anderson, M. R., Torigian, D. A., Tong, Y., Oyster, M. L., Porteous, M. K., Palmer, S. M., Arcasoy, S. M., Diamond, J. M., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202003-247oc · Cited by 15
Self-citationRecipient, donor, and surgical factors leading to primary graft dysfunction after lung transplant
Toyoda, T., Cerier, E. J., Manerikar, A. J., Kandula, V., Bharat, A., & Kurihara, C. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-22-974 · Cited by 15
“Recipient factors such as gender, race, obesity, sarcoidosis as the primary disease, and primary hypertension were risk factors (10-20).”
BackgroundInfluentialMICB Genomic Variant Is Associated with NKG2D-mediated Acute Lung Injury and Death
Aguilar, O. A., Qualls, A., Gonzalez-Hinojosa, M. D. R., Obeidalla, S. N., Kerchberger, V. E., Tsao, T., Singer, J. P., Looney, M. R., Raymond, W. W., Hays, S. R., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202303-0472oc · Cited by 16
Self-citationKortchinsky, T., Mussot, S., Rezaiguia, S., Artiguenave, M., Fadel, É., & Stéphan, F. (2016) · Clinical Transplantation · doi:10.1111/ctr.12805 · Cited by 14
Elgharably, H., Ayyat, K. S., Okamoto, T., Thuita, L., Unai, S., Bribriesco, A. C., Yun, J. J., Johnston, D. R., Ahmad, U., Murthy, S. C., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003756 · Cited by 15
Hydrogen: Potential Applications in Solid Organ Transplantation
Yang, F., Yu, L., Liu, R., Luo, X., Li, J., Zeng, F., Lu, S., Huang, X., & Lan, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6659310 · Cited by 14
Chacon‐Alberty, L., Ye, S., Daoud, D., Frankel, W. C., Virk, H., Mase, J., Hochman‐Mendez, C., Li, M., Sampaio, L. C., Taylor, D. A., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01900-y · Cited by 14
“PGD is a leading cause of early morbidity and mortality after lung transplantation and portends poor late outcomes [4, 5].”
BackgroundLung Transplantation and Atrial Septostomy in Pulmonary Arterial Hypertension
Norfolk, S. G., Lederer, D. J., & Tapson, V. F. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.09.002 · Cited by 16
Self-citationPediatric lung transplantation: 10 years of experience
de Camargo, P. C. L. B., Pato, E. Z. S., Campos, S. V., Afonso, J. E., Carraro, R. M., Costa, A. N., Teixeira, R. H. D. O. B., Samano, M. N., & Pêgo‐Fernandes, P. M. (2014) · Clinics · doi:10.6061/clinics/2014(sup01)10 · Cited by 15
“International data show that cardiopulmonary bypass is used more frequently in pediatric LTx compared with adult LTx, and its use is related to the development of primary graft dysfunction, smoking status of the donor, presence of reperfusion injury, and body mass index of the recipient (8,10,11).”
BackgroundLung transplantation in HIV seropositive recipients: An analysis of the UNOS registry
Donohue, J. K., Chan, E. G., Clifford, S., Ryan, J. P., Furukawa, M., Haidar, G., Bertani, A., Hage, C. A., & Sánchez, P. G. (2024) · Clinical Transplantation · doi:10.1111/ctr.15246 · Cited by 13
“34,35 This is of particular importance due to HIV + recipients having higher pre-transplant pulmonary arterial pressure.”
BackgroundEdström, D., Niroomand, A., Stenlo, M., Broberg, E., Hirdman, G., Ghaidan, H., Hyllén, S., Pierre, L., Olm, F., & Lindstedt, S. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.08.014 · Cited by 15
Loor, G., Warnecke, G., Villavicencio, M. A., Smith, M. A., Zhou, X. P., Kukreja, J., Ardehali, A. A., Hartwig, M. G., Daneshmand, M. A., Hertz, M. I., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103334 · Cited by 18
Ex Vivo Lung Perfusion with K(ATP) Channel Modulators Antagonize Ischemia Reperfusion Injury
Arni, S., Maeyashiki, T., Latshang, T. D., Opitz, I., & İnci, İ. (2021) · Cells · doi:10.3390/cells10092296 · Cited by 13
“Severe primary graft dysfunction is the primary cause of lung transplantation failure with early mortality, and has important financial consequences for the caring institutions, causing prolonged stays in intensive care units [3].”
BackgroundGao, P., Li, C., Wu, J., Zhang, P., Liu, X., Li, Y., Ding, J., Su, Y., Zhu, Y., He, W., et al. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02307-9 · Cited by 15
“Although the Report of the ISHLT Working Group does not recommend separately grading PGD for bilateral and single lung transplant recipients routinely [6], previous publications do show that single lung transplantation may have an elevated overall incidence of PGD [33, 42].”
BackgroundResultZeriouh, M., Mohite, P. N., Sabashnikov, A., Zych, B., Patil, N. P., García‐Sáez, D., Koch, A., Ghodsizad, A., Weymann, A., Soresi, S., et al. (2015) · Clinical Transplantation · doi:10.1111/ctr.12528 · Cited by 13
“Additionally, the overall incidence of grade 3 PGD, the leading cause of early morbidity and mortality after LTx (25, 27), was extremely low in our study accounting for 4.”
BackgroundResultPérez-Terán, P., Roca, O., Rodríguez-Palomares, J. F., Sacanell, J., Leal, S., Solé, J., Rochera, M. I., Román, A., Ruiz‐Rodríguez, J. C., Gea, J., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.05.026 · Cited by 13
Preprocurement In Situ Donor Lung Tissue Gene Expression Classifies Primary Graft Dysfunction Risk
Cantu, E., Yan, M., Suzuki, Y., Buckley, T., Galati, V., Majeti, N., Bermudez, C. A., Diamond, J. M., Christie, J. D., & Feng, R. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201912-2436le · Cited by 13
Self-citationOda, H. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.14989/doctor.k23760 · Cited by 13
Metadata
- Authors
- Diamond, J. M., Lee, J. C., Kawut, S. M., Shah, R. J., Localio, A. R., Bellamy, S. L., Lederer, D. J., Cantu, E., Kohl, B. A., Lama, V. N., Bhorade, S. M., Crespo, M., Demissie, E., Sonett, J., Wille, K., Orens, J., Shah, A. S., Weinacker, A., Arcasoy, S., Shah, P. D., Wilkes, D. S., Ware, L. B., Palmer, S. M., & Christie, J. D.
- Affiliations
- University of Pennsylvania (US)
- Columbia University (US)
- University of Michigan (US)
- University of Chicago (US)
- University of Pittsburgh (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Stanford University (US)
- Indiana University Indianapolis (US)
- Vanderbilt University (US)
- Duke University (US)
- Corresponding author
- Diamond, Joshua M.
- ORCID
- Diamond, Joshua M.
- Kawut, Steven M.
- Shah, Rupal J.
- Localio, A. Russell
- Bellamy, Scarlett L.
- Lederer, David J.
- Cantu, Edward
- Kohl, Benjamin A.
- Lama, Vibha N.
- Bhorade, Sangeeta M.
- Crespo, Maria
- Wille, Keith
- Shah, Ashish S.
- Weinacker, Ann
- Arcasoy, Selim
- Shah, Pali D.
- Wilkes, David S.
- Ware, Lorraine B.
- Palmer, Scott M.
- Christie, Jason D.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-01
- Volume
- 187
- Issue
- 5
- Pages
- 527-534
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC3733407
- OpenAlex
- W2073264366
- Cited by
- 687
- References
- 34
- Citations by year
- 2026: 35 · 2025: 55 · 2024: 73 · 2023: 65 · 2022: 54 · 2021: 58 · 2020: 46 · 2019: 44 · 2018: 48 · 2017: 53 · 2016: 46 · 2015: 42 · 2014: 45 · 2013: 15
- FWCI
- 48.59
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL096845, K24HL103836, R01HL114626, R01HL081619, R01HL087115, K23HL116656, K24HL115354)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- primary graft dysfunction, lung transplantation, risk factors, fraction of inspired oxygen, single lung transplantation, cardiopulmonary bypass, obesity, sarcoidosis, pulmonary arterial hypertension, mean pulmonary artery pressure, donor-recipient mismatch, donor sex, donor body mass index
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, United States, Multivariate Analysis, Logistic Models, Lung Transplantation, Primary Graft Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.